Dutasteride, tamsulosin, alfuzosin and dutasteride/tamsulosin combination for treating benign prostatic hyperplasia
Agency for Care Effectiveness (ACE)
Record ID 32018002526
English
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/details/dutasteride-tamsulosin-alfuzosin-and-dutasteride-tamsulosin-combination-for-treating-benign-prostatic-hyperplasia
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Singapore
MeSH Terms
- Prostatic Hyperplasia
- Dutasteride
- Tamsulosin
- 5-alpha Reductase Inhibitors
- Adrenergic alpha-1 Receptor Antagonists
- Urological Agents
Contact
Organisation Name:
Agency for Care Effectiveness (ACE)
Contact Address:
Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854
Contact Name:
ACE_HTA@moh.gov.sg
Contact Email:
ACE_HTA@moh.gov.sg
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.